IFNγ augments TKI efficacy by alleviating protein unfolding stress to promote GSDME-mediated pyroptosis in hepatocellular carcinoma
Abstract Tyrosine kinase inhibitors (TKIs) are the standard treatment for advanced hepatocellular carcinoma (HCC). However, their therapeutic efficacy is often limited by drug resistance, primarily driven by tumoral intrinsic mechanisms. In this study, we demonstrate that IFNγ in the tumor microenvi...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-07-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07839-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849235247932112896 |
|---|---|
| author | Xiaoxiao Li Fujia Lu Jie Zhou Xiong Li Yan Li Weijie Ye Jing Li Liguo Yang Shi Tang Yuhan Zhou Songlin Yin Yuan Gao Haotian Shang Tengfei Chao Xiang Cheng Qian Chu Weimin Wang |
| author_facet | Xiaoxiao Li Fujia Lu Jie Zhou Xiong Li Yan Li Weijie Ye Jing Li Liguo Yang Shi Tang Yuhan Zhou Songlin Yin Yuan Gao Haotian Shang Tengfei Chao Xiang Cheng Qian Chu Weimin Wang |
| author_sort | Xiaoxiao Li |
| collection | DOAJ |
| description | Abstract Tyrosine kinase inhibitors (TKIs) are the standard treatment for advanced hepatocellular carcinoma (HCC). However, their therapeutic efficacy is often limited by drug resistance, primarily driven by tumoral intrinsic mechanisms. In this study, we demonstrate that IFNγ in the tumor microenvironment can potentiate TKI response, and that ablation of IFNγ receptor on HCC cells leads to TKI resistance in vivo. Mechanistically, IFNγ synergizes with TKI to induce GSDME-mediated pyroptosis of HCC cells. The PERK-mediated unfolded protein response (UPR) protects HCC cells from TKI-induced pyroptosis. IFNγ attenuates PERK activation by inducing the expression of PDIA1, which alleviates the stress of protein unfolding. In vivo, PERK inhibition augments TKI therapy, and elevated PERK expression correlates with poor overall survival of patients with HCC. Moreover, IFNγ-producing CD8+ T cells can potentiate TKI efficacy. Combining PD-1 blockade to activate T-cell response with TKI therapy synergistically suppresses the growth of GSDME-expressing HCC tumors, which is further enhanced by the PERK inhibitor. Our findings reveal how IFNγ signaling modulates TKI response and demonstrate the potential of a sequential combination of ICB-mediated immunotherapy and TKI therapy for patients with GSDME+ HCC. T cell-derived IFNγ enhances TKI-induced pyroptosis in HCC. Mechanistic illustration of IFNγ secreted from CD8+ T cells enhancing TKI-induced GSDME-mediated pyroptosis in hepatocellular carcinoma via suppression of the PERK pathway. Created with BioRender.com. |
| format | Article |
| id | doaj-art-c62b0f2791f8480fa8f7732a68644b6b |
| institution | Kabale University |
| issn | 2041-4889 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Cell Death and Disease |
| spelling | doaj-art-c62b0f2791f8480fa8f7732a68644b6b2025-08-20T04:02:50ZengNature Publishing GroupCell Death and Disease2041-48892025-07-0116111410.1038/s41419-025-07839-yIFNγ augments TKI efficacy by alleviating protein unfolding stress to promote GSDME-mediated pyroptosis in hepatocellular carcinomaXiaoxiao Li0Fujia Lu1Jie Zhou2Xiong Li3Yan Li4Weijie Ye5Jing Li6Liguo Yang7Shi Tang8Yuhan Zhou9Songlin Yin10Yuan Gao11Haotian Shang12Tengfei Chao13Xiang Cheng14Qian Chu15Weimin Wang16Department of Immunology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and TechnologyDepartment of Immunology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and TechnologyDepartment of Immunology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and TechnologyDepartment of Gynecology & Obstetrics, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Immunology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and TechnologyDepartment of Immunology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and TechnologyDepartment of Immunology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and TechnologyDepartment of Immunology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and TechnologyDepartment of Immunology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and TechnologyDepartment of Immunology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and TechnologyDepartment of Immunology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and TechnologyDepartment of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Immunology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and TechnologyAbstract Tyrosine kinase inhibitors (TKIs) are the standard treatment for advanced hepatocellular carcinoma (HCC). However, their therapeutic efficacy is often limited by drug resistance, primarily driven by tumoral intrinsic mechanisms. In this study, we demonstrate that IFNγ in the tumor microenvironment can potentiate TKI response, and that ablation of IFNγ receptor on HCC cells leads to TKI resistance in vivo. Mechanistically, IFNγ synergizes with TKI to induce GSDME-mediated pyroptosis of HCC cells. The PERK-mediated unfolded protein response (UPR) protects HCC cells from TKI-induced pyroptosis. IFNγ attenuates PERK activation by inducing the expression of PDIA1, which alleviates the stress of protein unfolding. In vivo, PERK inhibition augments TKI therapy, and elevated PERK expression correlates with poor overall survival of patients with HCC. Moreover, IFNγ-producing CD8+ T cells can potentiate TKI efficacy. Combining PD-1 blockade to activate T-cell response with TKI therapy synergistically suppresses the growth of GSDME-expressing HCC tumors, which is further enhanced by the PERK inhibitor. Our findings reveal how IFNγ signaling modulates TKI response and demonstrate the potential of a sequential combination of ICB-mediated immunotherapy and TKI therapy for patients with GSDME+ HCC. T cell-derived IFNγ enhances TKI-induced pyroptosis in HCC. Mechanistic illustration of IFNγ secreted from CD8+ T cells enhancing TKI-induced GSDME-mediated pyroptosis in hepatocellular carcinoma via suppression of the PERK pathway. Created with BioRender.com.https://doi.org/10.1038/s41419-025-07839-y |
| spellingShingle | Xiaoxiao Li Fujia Lu Jie Zhou Xiong Li Yan Li Weijie Ye Jing Li Liguo Yang Shi Tang Yuhan Zhou Songlin Yin Yuan Gao Haotian Shang Tengfei Chao Xiang Cheng Qian Chu Weimin Wang IFNγ augments TKI efficacy by alleviating protein unfolding stress to promote GSDME-mediated pyroptosis in hepatocellular carcinoma Cell Death and Disease |
| title | IFNγ augments TKI efficacy by alleviating protein unfolding stress to promote GSDME-mediated pyroptosis in hepatocellular carcinoma |
| title_full | IFNγ augments TKI efficacy by alleviating protein unfolding stress to promote GSDME-mediated pyroptosis in hepatocellular carcinoma |
| title_fullStr | IFNγ augments TKI efficacy by alleviating protein unfolding stress to promote GSDME-mediated pyroptosis in hepatocellular carcinoma |
| title_full_unstemmed | IFNγ augments TKI efficacy by alleviating protein unfolding stress to promote GSDME-mediated pyroptosis in hepatocellular carcinoma |
| title_short | IFNγ augments TKI efficacy by alleviating protein unfolding stress to promote GSDME-mediated pyroptosis in hepatocellular carcinoma |
| title_sort | ifnγ augments tki efficacy by alleviating protein unfolding stress to promote gsdme mediated pyroptosis in hepatocellular carcinoma |
| url | https://doi.org/10.1038/s41419-025-07839-y |
| work_keys_str_mv | AT xiaoxiaoli ifngaugmentstkiefficacybyalleviatingproteinunfoldingstresstopromotegsdmemediatedpyroptosisinhepatocellularcarcinoma AT fujialu ifngaugmentstkiefficacybyalleviatingproteinunfoldingstresstopromotegsdmemediatedpyroptosisinhepatocellularcarcinoma AT jiezhou ifngaugmentstkiefficacybyalleviatingproteinunfoldingstresstopromotegsdmemediatedpyroptosisinhepatocellularcarcinoma AT xiongli ifngaugmentstkiefficacybyalleviatingproteinunfoldingstresstopromotegsdmemediatedpyroptosisinhepatocellularcarcinoma AT yanli ifngaugmentstkiefficacybyalleviatingproteinunfoldingstresstopromotegsdmemediatedpyroptosisinhepatocellularcarcinoma AT weijieye ifngaugmentstkiefficacybyalleviatingproteinunfoldingstresstopromotegsdmemediatedpyroptosisinhepatocellularcarcinoma AT jingli ifngaugmentstkiefficacybyalleviatingproteinunfoldingstresstopromotegsdmemediatedpyroptosisinhepatocellularcarcinoma AT liguoyang ifngaugmentstkiefficacybyalleviatingproteinunfoldingstresstopromotegsdmemediatedpyroptosisinhepatocellularcarcinoma AT shitang ifngaugmentstkiefficacybyalleviatingproteinunfoldingstresstopromotegsdmemediatedpyroptosisinhepatocellularcarcinoma AT yuhanzhou ifngaugmentstkiefficacybyalleviatingproteinunfoldingstresstopromotegsdmemediatedpyroptosisinhepatocellularcarcinoma AT songlinyin ifngaugmentstkiefficacybyalleviatingproteinunfoldingstresstopromotegsdmemediatedpyroptosisinhepatocellularcarcinoma AT yuangao ifngaugmentstkiefficacybyalleviatingproteinunfoldingstresstopromotegsdmemediatedpyroptosisinhepatocellularcarcinoma AT haotianshang ifngaugmentstkiefficacybyalleviatingproteinunfoldingstresstopromotegsdmemediatedpyroptosisinhepatocellularcarcinoma AT tengfeichao ifngaugmentstkiefficacybyalleviatingproteinunfoldingstresstopromotegsdmemediatedpyroptosisinhepatocellularcarcinoma AT xiangcheng ifngaugmentstkiefficacybyalleviatingproteinunfoldingstresstopromotegsdmemediatedpyroptosisinhepatocellularcarcinoma AT qianchu ifngaugmentstkiefficacybyalleviatingproteinunfoldingstresstopromotegsdmemediatedpyroptosisinhepatocellularcarcinoma AT weiminwang ifngaugmentstkiefficacybyalleviatingproteinunfoldingstresstopromotegsdmemediatedpyroptosisinhepatocellularcarcinoma |